Medicaid HEDIS® Annual Rates.
Molina’s scores for the past two years are below. You can see how Molina performs compared to our target goal.
Measure |
2023 Rate |
2023 Goal |
2024 Rate |
2024 Goal |
Adherence to Antipsychotic Medications for Individuals with Schizophrenia (SAA) |
70.09% |
64.90% |
61.75% |
66.15% |
Annual Dental Visits (ADV) Total |
NB |
54.60% |
|
|
Antidepressant Medication Management (AMM) Effective Continuation Phase Treatment |
49.97% |
46.74% |
43.60% |
48.16% |
Appropriate Testing for Pharyngitis (CWP) |
35.00% |
77.56% |
43.19% |
85.11% |
Appropriate Treatment for Upper Respiratory Infection (URI) Total |
93.09% |
93.08% |
89.16% |
91.27% |
Asthma Medication Ratio (AMR) Total |
61.84% |
69.41% |
58.68% |
70.56% |
Avoidance of Antibiotic Treatment for Acute Bronchitis / Bronchiolitis (AAB) |
54.12% |
66.19% |
53.76% |
67.03% |
Blood Pressure Control (<140/90) for Patients With Diabetes (BPD) |
63.26% |
68.61% |
67.88% |
71.78% |
Breast Cancer Screening (BCS) |
51.83% |
55.25% |
|
|
Breast Cancer Screening (BCS-E) |
51.72% |
54.94% |
51.75% |
56.66% |
Cervical Cancer Screening (CCS) |
51.09% |
59.85% |
50.36% |
60.10% |
Childhood Immunization Status (CIS) Combination #10 |
33.33% |
35.04% |
26.28% |
31.32% |
Chlamydia Screening in Women (CHL) Total |
61.48% |
61.07% |
65.28% |
61.46% |
Controlling High Blood Pressure (CBP) |
58.64% |
65.45% |
67.88% |
67.40% |
Diabetes Screening for People with Schizophrenia or Bipolar Disorder Who Are Using Antipsychotic Medications (SSD) |
80.53% |
80.86% |
86.42% |
83.51% |
Eye Exam for Patients With Diabetes (EED) |
53.04% |
56.20% |
54.01% |
57.09% |
Follow-Up After Emergency Department Visit for Alcohol and Other Drug Abuse or Dependence (FUA) 7-Day Follow-Up Total |
17.85% |
27.73% |
19.99% |
27.62% |
Follow-Up After Emergency Department Visit for Mental Illness (FUM) 7-Day Follow-Up Total |
28.36% |
46.35% |
17.07% |
44.33% |
Follow-Up After Hospitalization for Mental Illness (FUH) 7-Day Follow-Up Total |
16.94% |
41.03% |
3.82% |
42.86% |
Follow-Up After High-Intensity Care for Substance Use Disorder (FUI) 7-Day Follow-Up Total |
16.67% |
37.31% |
8.08% |
37.64% |
Follow-Up for Children Prescribed ADHD Medication (ADD) Continuation and Maintenance Phase |
46.26% |
57.90% |
44.44% |
56.86% |
Follow-Up for Children Prescribed ADHD Medication (ADD-E) Continuation and Maintenance Phase |
|
|
44.44% |
56.83% |
Hemoglobin A1c Control for Patients With Diabetes (HBD) HbA1c Control (<8%) |
56.45% |
55.72% |
55.23% |
59.64% |
Immunizations for Adolescents (IMA) Combination #2 |
32.91% |
38.93% |
34.31% |
38.69% |
Initiation and Engagement of Alcohol and Other Drug Dependence Treatment (IET) Engagement of AOD Treatment Total |
8.46% |
16.94% |
7.13% |
16.78% |
Kidney Health Evaluation for Patients with Diabetes (KED) |
48.18% |
38.80% |
49.91% |
42.10% |
Metabolic Monitoring for Children and Adolescents on Antipsychotics (APM) Blood Glucose and Cholesterol Testing Total |
40.79% |
39.01% |
42.63% |
41.92% |
Metabolic Monitoring for Children and Adolescents on Antipsychotics (APM-E) Blood Glucose and Cholesterol Testing Total |
|
|
42.63% |
41.41% |
Pharmacotherapy for Opioid Use Disorder (POD) Total |
21.51% |
31.93% |
10.48% |
29.01% |
Pharmacotherapy Management of COPD Exacerbation (PCE) Systemic Corticosteroids |
65.61% |
75.79% |
60.29% |
74.78% |
Pharmacotherapy Management of COPD Exacerbation (PCE) Bronchodilator |
86.07% |
86.96% |
82.90% |
86.54% |
Plan All-Cause Readmissions (PCR) Observed-to-Expected Ratio 18-64 Years |
86.88% |
≤ 92.72% |
89.48% |
≤91.24% |
Prenatal and Postpartum Care (PPC) Timeliness of Prenatal Care |
84.18% |
86.86% |
82.48% |
86.89% |
Prenatal and Postpartum Care (PPC) Postpartum Care |
82.00% |
80.78% |
79.56% |
82.48% |
Prenatal Immunization Status (PRS) Combination Rate |
22.97% |
25.81% |
|
|
Prenatal Immunization Status (PRS-E) Combination Rate |
22.97% |
25.81% |
24.36% |
24.92% |
Risk of Continued Opioid Use (COU) 31-Day Total |
2.74% |
≤ 2.45% |
2.65% |
≤ 2.79% |
Statin Therapy for Patients with Cardiovascular Disease (SPC) Received Statin Therapy Total |
55.46% |
81.64% |
79.69% |
83.00% |
Statin Therapy for Patients with Cardiovascular Disease (SPC) Statin Adherence 80% Total |
83.88% |
73.63% |
70.23% |
74.07% |
Statin Therapy for Patients with Diabetes (SPD) Received Statin Therapy |
69.49% |
67.07% |
68.26% |
67.01% |
Statin Therapy for Patients with Diabetes (SPD) Statin Adherence 80% |
82.00% |
70.37% |
66.41% |
70.91% |
Use of First-Line Psychosocial Care for Children and Adolescents on Antipsychotics (APP) Total |
29.46% |
63.89% |
57.81% |
64.10% |
Use of Imaging Studies for Low Back Pain (LBP) |
73.36% |
75.44% |
70.42% |
72.74% |
Use of Opioids at High Dosage (HDO) |
2.09% |
≤ 2.19% |
1.75% |
≤ 2.14% |
Use of Opioids from Multiple Providers (UOP) Multiple Prescribers and Multiple Pharmacies |
0.17% |
≤ 0.87% |
0.78% |
≤ 1.22% |
Weight Assessment and Counseling for Nutrition and Physical Activity for Children/Adolescents (WCC) BMI Percentile |
82.97% |
83.21% |
87.35% |
86.20% |
NA = Not Available Due to Small Denominator
NB = No Benefit
NR = Not Reported
NQ = Not Required
BR = Biased Rate